Featured Latest News

Dr Reddy’s Launches New Generic Ozempic Brands Amid Supply Disruption

By Uniquetimesorg October 23, 2026 0

Dr Reddy’s Laboratories has expanded its portfolio of generic semaglutide medicines in India with two new brands, Obeda Pro and Obeda Plus, following supply disruptions affecting its original Obeda injection. The new products are manufactured by Hetero Labs, while the original injectable was produced by OneSource Specialty Pharma. Distributors told Reuters that the company Continue Reading

Featured Latest News

Indian Firms Launch Low-Cost Ozempic, Wegovy Generics

By Uniquetimesorg March 23, 2026 0

Indian pharmaceutical companies have rapidly introduced cheaper versions of Novo Nordisk’s diabetes drug Ozempic and weight-loss drug Wegovy following the expiration of semaglutide’s patent in India. Prices for these generics are about 70% lower than the original, with dozens of brands expected to hit the market as early as this year. Analysts predict over 40 […]Continue Reading

Featured Latest News

Zydus Life Settles $120M Patent Dispute with Astellas

By Uniquetimesorg February 12, 2026 0

India’s Zydus Lifesciences and its U.S. unit have agreed to pay $120 million to Astellas Pharma to resolve a patent dispute over the Japanese company’s bladder disorder drug, Mirabegron. Under the settlement, Zydus will also pay a pre-paid per-unit licensing fee for sales of its generic version in the U.S. until September 2027, allowing it […]Continue Reading

Entertainment Featured Latest News

Sun Pharma Wins Approval to Launch Generic Wegovy in India

By Uniquetimesorg January 23, 2026 0

Sun Pharmaceutical Industries, India’s largest drugmaker by revenue, has received regulatory approval to manufacture and sell a generic version of Novo Nordisk’s blockbuster weight-loss drug Wegovy in India, the company said on Friday. The generic drug, semaglutide, will be launched under the brand name Noveltreat after the expiry of Novo Nordisk’s patent in March 2026. Continue Reading